Fred Callori - May 16, 2022 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
Director
Signature
/s/ Eric W. Blanchard, Attorney-in-Fact
Stock symbol
LABP
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4
Date filed
5/18/2022, 04:30 PM
Previous filing
Aug 31, 2021
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Stock Option (right to buy) Award $0 +18K $0.00 18K May 16, 2022 Common Stock 18K $0.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to this option will vest and become exercisable in equal monthly installments commencing May 19, 2022, subject to the Reporting Person providing continuous service to the Issuer.